TRANSTHERA-B Board Endorses 2026 H-Share Award Scheme, Seeks Shareholder and HKEX Nod

Bulletin Express

04/07

TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers.

The programme, cleared by the board on 7 April 2026, allows the Scheme Administrator to issue awards in the form of share options or share awards. Grants may be satisfied with treasury stock, newly issued H shares or existing H shares.

Implementation hinges on two conditions: 1. Shareholder approval via a special resolution at an upcoming extraordinary general meeting (EGM). 2. Listing Committee approval for the listing and dealing of any new H shares issued under the scheme.

Subject to EGM approval, the board also seeks authority for the Scheme Administrator to execute all documents and actions necessary to implement the plan.

A circular outlining full details and the EGM notice will be released in due course. Until formal approvals are obtained, shareholders and potential investors are advised to exercise caution when trading the company’s securities.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1148728314"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1148728314\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1148728314?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-07 19:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148728314","market":"us","top_or_hot":-1,"title":"TRANSTHERA-B Board Endorses 2026 H-Share Award Scheme, Seeks Shareholder and HKEX Nod","media":"Bulletin Express","content":"<p>TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers.</p>\n<p>The programme, cleared by the board on 7 April 2026, allows the Scheme Administrator to issue awards in the form of share options or share awards. Grants may be satisfied with treasury stock, newly issued H shares or existing H shares.</p>\n<p>Implementation hinges on two conditions:\n1. Shareholder approval via a special resolution at an upcoming extraordinary general meeting (EGM).\n2. Listing Committee approval for the listing and dealing of any new H shares issued under the scheme.</p>\n<p>Subject to EGM approval, the board also seeks authority for the Scheme Administrator to execute all documents and actions necessary to implement the plan.</p>\n<p>A circular outlining full details and the EGM notice will be released in due course. Until formal approvals are obtained, shareholders and potential investors are advised to exercise caution when trading the company’s securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TRANSTHERA-B Board Endorses 2026 H-Share Award Scheme, Seeks Shareholder and HKEX Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTRANSTHERA-B Board Endorses 2026 H-Share Award Scheme, Seeks Shareholder and HKEX Nod\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-07 19:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers.</p>\n<p>The programme, cleared by the board on 7 April 2026, allows the Scheme Administrator to issue awards in the form of share options or share awards. Grants may be satisfied with treasury stock, newly issued H shares or existing H shares.</p>\n<p>Implementation hinges on two conditions:\n1. Shareholder approval via a special resolution at an upcoming extraordinary general meeting (EGM).\n2. Listing Committee approval for the listing and dealing of any new H shares issued under the scheme.</p>\n<p>Subject to EGM approval, the board also seeks authority for the Scheme Administrator to execute all documents and actions necessary to implement the plan.</p>\n<p>A circular outlining full details and the EGM notice will be released in due course. Until formal approvals are obtained, shareholders and potential investors are advised to exercise caution when trading the company’s securities.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02617","symbol_name":"藥捷安康-B","start_time":0,"source_url":"","article_id":"1148728314","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148728314","pubTimestamp":1775562327,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02617":"药捷安康-B"},"translate_title":"Tranthera-B董事会批准2026年H股奖励计划，寻求股东和港交所认可","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02617":1},"content_text":"TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers.\nThe programme, cleared by the board on 7 April 2026, allows the Scheme Administrator to issue awards in the form of share options or share awards. Grants may be satisfied with treasury stock, newly issued H shares or existing H shares.\nImplementation hinges on two conditions:\n1. Shareholder approval via a special resolution at an upcoming extraordinary general meeting (EGM).\n2. Listing Committee approval for the listing and dealing of any new H shares issued under the scheme.\nSubject to EGM approval, the board also seeks authority for the Scheme Administrator to execute all documents and actions necessary to implement the plan.\nA circular outlining full details and the EGM notice will be released in due course. Until formal approvals are obtained, shareholders and potential investors are advised to exercise caution when trading the company’s securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}